Andreas Halvorsen's DNA Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 3.58 M shares of Ginkgo Bioworks Holdings, Inc. (DNA) worth $29.73 M, representing 0.08% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in DNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 2 M shares. Largest reduction occurred in Q1 2022, reducing 7.2 M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Ginkgo Bioworks Holdings (DNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Ginkgo Bioworks Holdings (DNA) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +2 M | Add 126.81% | 3.58 M | $53.20 |
| Q4 2022 | -968,725 | Reduce 38.05% | 1.58 M | $67.60 |
| Q3 2022 | +1.87 M | Add 275.99% | 2.55 M | $124.80 |
| Q2 2022 | -599,276 | Reduce 46.95% | 677,103 | $95.20 |
| Q1 2022 | -7.2 M | Reduce 84.94% | 1.28 M | $161.20 |
| Q3 2021 | +8.48 M | New Buy | 8.48 M | $463.60 |
Andreas Halvorsen's Ginkgo Bioworks Holdings Investment FAQs
Andreas Halvorsen first purchased Ginkgo Bioworks Holdings, Inc. (DNA) in Q3 2021, acquiring 8,476,379 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Ginkgo Bioworks Holdings, Inc. (DNA) for 18 quarters since Q3 2021.
Andreas Halvorsen's largest addition to Ginkgo Bioworks Holdings, Inc. (DNA) was in Q3 2021, adding 8,476,379 shares worth $3.93 B.
According to the latest 13F filing for Q4 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 3,577,128 shares of Ginkgo Bioworks Holdings, Inc. (DNA), valued at approximately $29.73 M.
As of the Q4 2025 filing, Ginkgo Bioworks Holdings, Inc. (DNA) represents approximately 0.08% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Ginkgo Bioworks Holdings, Inc. (DNA) was 8,476,379 shares, as reported at the end of Q3 2021.